Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | Dr. Mathieu BurtnykPresident | 11,62k | 76,77k | Derivative Exercise and Retained Stock | 6,61 | 55,17k | 26,68% |
| 2026-06-17 | Mr. Rashed DewanCFO | 7,75k | 51,18k | Derivative Exercise and Retained Stock | 6,61 | 86,07k | 9,89% |
| 2026-06-17 | Mr. Thomas TamberrinoChief Commercial Officer | 10,55k | 69,68k | Derivative Exercise and Retained Stock | 6,61 | 49,79k | 26,87% |
| 2026-06-17 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 70,35k | 464,88k | Derivative Exercise and Retained Stock | 6,61 | 729,01k | 10,68% |
| 2026-06-11 | Mr. Vafa JamaliDirector | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 6,72 | 20,00k | - |
| 2026-06-11 | Mr. Thomas G. WellnerDirector | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 6,72 | 20,00k | - |
| 2026-06-11 | Mr. Frank BaylisIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 6,72 | 20,00k | - |
| 2026-03-20 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 20,00k | 101,92k | Kauf | 5,10 | 658,66k | 3,13% |
| 2025-12-23 | Mr. Thomas TamberrinoChief Commercial Officer | 13,91k | 99,94k | Kauf | 7,19 | 39,24k | 54,90% |
| 2025-12-23 | Dr. Arthur L. J. RosenthalIndependent Director | 13,90k | 101,47k | Kauf | 7,30 | 58,84k | 30,93% |
| 2025-12-23 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 13,40k | 100,00k | Kauf | 7,47 | 638,66k | 2,14% |
| 2025-11-24 | Ms. Murielle LortieIndependent Director | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 5,35k | 15,52% |
| 2025-11-24 | Krishan ShahInsider | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 2,20k | 48,48% |
| 2025-11-24 | Dr. Arthur L. J. RosenthalIndependent Director | 868,00 | 5,28k | Derivative Exercise and Retained Stock | 6,08 | 44,94k | 1,97% |
| 2025-11-24 | Mr. Brian R. EllacottIndependent Lead Director | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 70,20k | 1,03% |
| 2025-11-24 | Dr. Cynthia LavoieIndependent Director | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 8,20k | 9,61% |
| 2025-11-19 | Dr. Mathieu BurtnykPresident | 1,49k | 9,08k | Derivative Exercise and Retained Stock | 6,11 | 43,55k | 3,53% |
| 2025-11-20 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 4,84k | 29,51k | Derivative Exercise and Retained Stock | 6,10 | 625,26k | 0,78% |
| 2025-11-20 | Mr. Rashed DewanCFO | 1,49k | 9,06k | Derivative Exercise and Retained Stock | 6,10 | 78,33k | 1,93% |
| 2024-11-18 | Krishan ShahInsider | 5,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 5,00k | - |
| 2024-09-08 | Krishan ShahInsider | 1,48k | 9,06k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 1,48k | - |
| 2024-09-08 | Dr. Arthur L. J. RosenthalIndependent Director | 1,77k | 10,85k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 44,07k | 4,19% |
| 2024-09-08 | Mr. Brian R. EllacottIndependent Lead Director | 1,48k | 9,06k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 69,48k | 2,18% |
| 2024-09-08 | Ms. Murielle LortieIndependent Director | 1,48k | 9,06k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 4,63k | 47,08% |
| 2025-09-09 | Dr. Cynthia LavoieIndependent Director | 756,00 | 3,29k | Derivative Exercise and Retained Stock | 4,35 | 7,48k | 11,24% |
| 2025-09-09 | Dr. Mathieu BurtnykPresident | 3,05k | 12,41k | Derivative Exercise and Retained Stock | 4,07 | 42,06k | 7,81% |
| 2025-09-08 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 16,67k | 67,90k | Derivative Exercise and Retained Stock | 4,07 | 620,42k | 2,76% |
| 2025-09-08 | Mr. Rashed DewanCFO | 16,67k | 67,90k | Derivative Exercise and Retained Stock | 4,07 | 76,84k | 27,70% |
| 2025-08-21 | Dr. Mathieu BurtnykPresident | 6,76k | 29,01k | Derivative Exercise and Retained Stock | 4,29 | 39,02k | 20,97% |
| 2025-08-15 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 16,67k | 71,96k | Derivative Exercise and Retained Stock | 4,32 | 603,76k | 2,84% |
| 2025-08-15 | Mr. Rashed DewanCFO | 13,33k | 57,57k | Derivative Exercise and Retained Stock | 4,32 | 60,17k | 28,47% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
